selenocysteine has been researched along with Cancer of Liver in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Lei, J; Li, Y; Lin, B; Su, J; Wang, Y; Wu, Y; Zhang, K; Zheng, R; Zhu, B | 1 |
| Björnstedt, M; Kiss, A; Kontsek, E; Lendvai, G; Schaff, Z; Selvam, A; Szakos, A; Szekerczés, T | 1 |
| Ding, J; Fan, B; Huang, C; Li, J; Li, Y; Qi, C; Zhang, J; Zhang, Y | 1 |
| Gangapurkar, B; Jariwalla, RJ; Nakamura, D | 1 |
| Bravo, L; Cámara, C; Cuello, S; Goya, L; Madrid, Y; Martín, MA; Mateos, R; Ramos, S | 1 |
| Cox, AG; Taylor, EW; Zhang, W | 1 |
6 other study(ies) available for selenocysteine and Cancer of Liver
| Article | Year |
|---|---|
L-Selenocysteine induced HepG-2 cells apoptosis through reactive oxygen species-mediated signaling pathway.
Topics: Apoptosis; Cell Line, Tumor; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Selenocysteine; Signal Transduction | 2022 |
The Effect of Methylselenocysteine and Sodium Selenite Treatment on microRNA Expression in Liver Cancer Cell Lines.
Topics: Anticarcinogenic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Selenocysteine; Sodium Selenite; Trace Elements; Tumor Cells, Cultured | 2020 |
Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway.
Topics: Alanine Transaminase; Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Aspartate Aminotransferases; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Disease Models, Animal; gamma-Glutamyltransferase; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Nitric Oxide Synthase; Rats; Selenocysteine; Treatment Outcome | 2021 |
Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
Topics: Adenocarcinoma; Adolescent; Adult; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cysteine; Epithelial Cells; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Organoselenium Compounds; Selenium Compounds; Selenocysteine; Selenomethionine; Skin Neoplasms | 2009 |
Selenium methylselenocysteine protects human hepatoma HepG2 cells against oxidative stress induced by tert-butyl hydroperoxide.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cysteine; Glutathione; Humans; Liver Neoplasms; Malondialdehyde; Organoselenium Compounds; Oxidative Stress; Reactive Oxygen Species; Selenocysteine; tert-Butylhydroperoxide; Time Factors | 2007 |
Hepatitis C virus encodes a selenium-dependent glutathione peroxidase gene. Implications for oxidative stress as a risk factor in progression to hepatocellular carcinoma.
Topics: Amino Acid Sequence; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Disease Progression; Glutathione Peroxidase; Hepacivirus; Humans; Liver Neoplasms; Models, Genetic; Molecular Sequence Data; Oxidative Stress; Reading Frames; Risk Factors; Selenium; Selenocysteine | 1999 |